Position in AKAN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,969
New position
Shares Held
11,417
first reported quarter
Ownership
2.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 5 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $27,950,471 across 45 Drug Manufacturers - Specialty & Generic names. AKAN ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
379,350 | $3,797,293 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
28,525 | $2,193,572 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
91,114 | $2,059,176 | |
| 4 | VTRS |
Viatris Inc
|
144,138 | $1,947,304 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
87,736 | $1,718,748 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
26,428 | $1,566,387 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,626 | $1,324,607 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,324 | $1,320,920 |
All Filings in AKAN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,969 | 11,417 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||